| Device |
system, transdermal delivery, cder or cber led |
| Definition |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
| Physical State |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
| Technical Method |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
| Target Area |
Skin. |
| Review Panel |
General Hospital |
| Product Code | QIX |
| Premarket Review |
CDER Division
(CDER)
|
|
Not Classified Reason
|
Unknown
|
| Submission Type |
Contact ODE
|
| Device Class |
Not Classified
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |